11132 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 223 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x RNA TS TPMi x
A1BGAlpha-1-B glycoproteinPlasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Liver cancer: 3.97e-4
Tissue enrichedliver:505.6
A1CFAPOBEC1 complementation factorPredicted intracellular proteins
NucleoplasmTissue enhancedliver:76.0
small intestine:29.8
A2MAlpha-2-macroglobulinCancer-related genes
Candidate cardiovascular disease genes
Plasma proteins
Predicted secreted proteins
Expressed in all
AAASAladin WD repeat nucleoporinDisease related genes
Potential drug targets
Predicted intracellular proteins
Transporters
Nuclear membrane
Centrosome
Cytosol
Renal cancer: 2.93e-4
Expressed in all
AACSAcetoacetyl-CoA synthetaseEnzymes
Predicted membrane proteins
VesiclesExpressed in all
AADATAminoadipate aminotransferaseEnzymes
Predicted intracellular proteins
Vesicles
Plasma membrane
Colorectal cancer: 5.59e-4
Tissue enhancedliver:34.7
AAED1AhpC/TSA antioxidant enzyme domain containing 1Predicted intracellular proteins
Renal cancer: 3.26e-5
Expressed in all
AAGABAlpha- and gamma-adaptin binding proteinDisease related genes
Predicted intracellular proteins
Nuclear speckles
Cytosol
Renal cancer: 1.36e-4
Thyroid cancer: 9.48e-4
Expressed in all
AAK1AP2 associated kinase 1Enzymes
Predicted intracellular proteins
Plasma membrane
Cytosol
Ovarian cancer: 3.19e-4
Tissue enrichedparathyroid gland:389.6
AAMDCAdipogenesis associated Mth938 domain containingPredicted intracellular proteins
Nucleoplasm
Cytosol
Expressed in all
AAMPAngio associated migratory cell proteinPlasma proteins
Predicted intracellular proteins
Microtubules
Cytosol
Liver cancer: 4.94e-7
Endometrial cancer: 1.62e-4
Expressed in all
AAR2AAR2 splicing factor homologPredicted intracellular proteins
CytosolLiver cancer: 1.83e-6
Expressed in all
AARSAlanyl-tRNA synthetaseDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
CytosolExpressed in all
AARS2Alanyl-tRNA synthetase 2, mitochondrialCancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
MitochondriaMixed
AARSD1Alanyl-tRNA synthetase domain containing 1Predicted intracellular proteins
Nuclear membrane
Cytosol
Renal cancer: 1.67e-6
Expressed in all
AASDHAminoadipate-semialdehyde dehydrogenasePredicted intracellular proteins
Predicted membrane proteins
Mixed
AASDHPPTAminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferasePredicted intracellular proteins
Renal cancer: 4.27e-4
Expressed in all
AASSAminoadipate-semialdehyde synthaseDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Vesicles
Mitochondria
Liver cancer: 9.81e-4
Mixed
AATFApoptosis antagonizing transcription factorPredicted intracellular proteins
Renal cancer: 4.14e-5
Liver cancer: 6.62e-5
Expressed in all
AATKApoptosis associated tyrosine kinaseEnzymes
Predicted intracellular proteins
Predicted membrane proteins
MitochondriaTissue enhancedcerebral cortex:36.4
duodenum:23.4
ABAT4-aminobutyrate aminotransferaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
MitochondriaRenal cancer: 5.44e-8
Liver cancer: 5.36e-5
Lung cancer: 5.93e-4
Tissue enhancedcerebral cortex:164.5
kidney:135.3
liver:175.2
ABCA1ATP binding cassette subfamily A member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleoplasm
Vesicles
Mixed
ABCA2ATP binding cassette subfamily A member 2Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enrichedcerebral cortex:97.9
ABCA5ATP binding cassette subfamily A member 5Predicted intracellular proteins
Predicted membrane proteins
Transporters
NucleusPancreatic cancer: 9.97e-5
Expressed in all
ABCA7ATP binding cassette subfamily A member 7Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Golgi apparatus
Plasma membrane
Cell Junctions
Endometrial cancer: 1.12e-4
Colorectal cancer: 7.26e-4
Mixed
ABCB1ATP binding cassette subfamily B member 1Cancer-related genes
CD markers
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleoplasm
Focal adhesion sites
Cytosol
Renal cancer: 2.95e-4
Pancreatic cancer: 3.33e-4
Tissue enhancedadrenal gland:137.8
small intestine:82.4
ABCB10ATP binding cassette subfamily B member 10Plasma proteins
Predicted membrane proteins
Transporters
Expressed in all
ABCB4ATP binding cassette subfamily B member 4Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleoplasm
Plasma membrane
Actin filaments
Focal adhesion sites
Tissue enrichedliver:69.3
ABCB6ATP binding cassette subfamily B member 6 (Langereis blood group)Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Nucleoplasm
Golgi apparatus
Plasma membrane
Mitochondria
Cytosol
Renal cancer: 1.52e-7
Liver cancer: 9.45e-7
Expressed in all
ABCB7ATP binding cassette subfamily B member 7Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
MitochondriaRenal cancer: 5.31e-6
Expressed in all
ABCB8ATP binding cassette subfamily B member 8Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleus
Mitochondria
Pancreatic cancer: 3.34e-4
Renal cancer: 5.88e-4
Head and neck cancer: 5.91e-4
Expressed in all
ABCB9ATP binding cassette subfamily B member 9Predicted intracellular proteins
Predicted membrane proteins
Transporters
VesiclesGlioma: 4.62e-4
Tissue enhancedtestis:23.8
ABCC1ATP binding cassette subfamily C member 1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Plasma membraneRenal cancer: 1.55e-6
Liver cancer: 5.42e-5
Mixed
ABCC10ATP binding cassette subfamily C member 10Predicted intracellular proteins
Predicted membrane proteins
Transporters
Renal cancer: 1.90e-4
Expressed in all
ABCC2ATP binding cassette subfamily C member 2Cancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Renal cancer: 1.93e-5
Group enrichedduodenum:43.5
gallbladder:42.7
kidney:20.9
liver:67.6
small intestine:49.5
ABCC3ATP binding cassette subfamily C member 3Cancer-related genes
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membraneRenal cancer: 4.68e-6
Pancreatic cancer: 9.57e-4
Mixed
ABCC4ATP binding cassette subfamily C member 4Plasma proteins
Predicted membrane proteins
Transporters
Renal cancer: 2.25e-10
Endometrial cancer: 9.89e-4
Tissue enhancedprostate:70.4
ABCC5ATP binding cassette subfamily C member 5Cancer-related genes
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleus
Plasma membrane
Cell Junctions
Liver cancer: 6.78e-8
Prostate cancer: 3.40e-4
Expressed in all
ABCC6ATP binding cassette subfamily C member 6Cancer-related genes
Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Plasma membraneLiver cancer: 3.82e-4
Tissue enhancedkidney:16.9
liver:23.4
ABCD1ATP binding cassette subfamily D member 1Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Renal cancer: 5.50e-4
Expressed in all
ABCD3ATP binding cassette subfamily D member 3Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
PeroxisomesColorectal cancer: 1.16e-5
Renal cancer: 4.84e-5
Expressed in all
ABCD4ATP binding cassette subfamily D member 4Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
ABCE1ATP binding cassette subfamily E member 1Predicted intracellular proteins
CytosolPancreatic cancer: 1.88e-4
Liver cancer: 6.29e-4
Colorectal cancer: 8.69e-4
Expressed in all
ABCF1ATP binding cassette subfamily F member 1Plasma proteins
Predicted intracellular proteins
CytosolLiver cancer: 9.47e-4
Mixed
ABCF2ATP binding cassette subfamily F member 2Predicted intracellular proteins
CytosolLiver cancer: 9.52e-6
Expressed in all
ABCF3ATP binding cassette subfamily F member 3Predicted intracellular proteins
Nucleoli
Cytosol
Liver cancer: 4.16e-5
Expressed in all
ABCG2ATP binding cassette subfamily G member 2 (Junior blood group)Cancer-related genes
CD markers
Predicted intracellular proteins
Predicted membrane proteins
Nucleus
Plasma membrane
Tissue enhancedsmall intestine:113.8
ABCG5ATP binding cassette subfamily G member 5Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
NucleusLiver cancer: 2.60e-5
Group enrichedduodenum:56.5
liver:28.4
small intestine:56.2
ABCG8ATP binding cassette subfamily G member 8Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
VesiclesGroup enrichedduodenum:50.0
liver:34.0
small intestine:55.5
ABHD10Abhydrolase domain containing 10Enzymes
Predicted secreted proteins
MitochondriaRenal cancer: 4.72e-9
Cervical cancer: 7.57e-4
Expressed in all
Page of 223 | next »